X
GO
← Return to Councils

Public Policy Council Leadership

Director: Jessica Hill



Council Members:

Barbara Giacomelli, PharmD, MBA, FASHP
VP Advisory
Pharmaceutical Solutions and Services
McKesson RxO 

Jessica Hill, PharmD, BCPS, BCACP
Corporate Assistant Director, Clinical Pharmacy
RWJBarnabas Health

Carlo Lupano, RPh, CCP, MBA, FASHP
Pharmacy Manager
Residency Program Director
Valley-Mount Sinai Comprehensive Cancer Care
Robert & Audrey Luckow Pavilion

Neha Siddiqui, PharmD
PGY-1 Pharmacy Practice Resident
The Valley Hospital Pharmacy Department
Valley Health System


The Council on Public Policy looks at what is going on in the local, state and national stage regarding any aspect of pharmacy. The members of this council are looking out for you and the profession.

To join this Council, please print and fill out the Council Involvement Form.

What is Advocacy?

Advocacy isn’t just about what happens in Washington, D.C. It’s about what you can do close to home as you build relationships with your elected officials. The council members represent you to elected officials as well as make it as easy as possible for you to connect with them. Sometimes it is writing a letter or signing a petition and sometimes it is attending a meeting.

Strong advocacy builds a strong profession.

Some of the topics the council is involved with are:

  • Obtaining Provider Status
  • Collaborative Practice regulations (aka Collaborative Drug Therapy Management (CDTM)
  • Opioid epidemic and its laws and regulations
  • Providing education on what Health System Pharmacists do
  • UPS 797 and USP 800
  • 340b
  

 

Public Policy Council Updates for May 2021

The Council on Public Policy has continued to meet monthly. Council members attended the Board of Pharmacy Meeting and ASHP State Legislative and Regulatory Conference Call. Committee members drafted a letter regarding “White-Bagging” to the Board of Pharmacy that is currently under review by NJSHP Board. The Council on Public Policy plans to assertively advocate with the Board of Pharmacy and others to protect patients, pharmacists and health systems from the negative downstream effects of insurer driven White-Bagging requirements. The Council also reviewed the Pharmacy and Medically Underserved Areas Enhancement Act of 2021. NJSHP Members will receive more information about how to support this important legislation in the coming weeks. 

The Council on Public Policy would like to thank and recognize Dr. Julie Kalabalik-Hoganson for her service as Director of the Council over the past year. Her dedication and commitment to advancing practice has helped grow the work of the council immensely. 

 

ASHP Policy Week

NJSHP leadership and the Public Policy Council participated in ASHP’s Policy Week last week, meeting with representatives of the offices of Menendez, Booker, and Sherrill on the following issues:

  • 340B drug pricing program

  • COVID-19 testing and vaccination reimbursement

  • Telehealth services reimbursement

  • Eliminating X-waivers to increase providers who can prescribe MAT for opioid addiction

  

 

CMS Should Make Virtual Supervision Flexibility Permanent

NJSHP members,

NJSHP partnered with health-systems and professional groups to demonstrate support of CMS making permanent the current temporary regulatory flexibility allowing physicians to provide direct supervision of clinical staff virtually, using real-time audio/video technology. Attached is the letter sent to Administrator Seema Verma.

Regards,
Julie Kalabalik-Hoganson, PharmD, BCPS, BCCCP
Director, Public Policy
New Jersey Society of Health-System Pharmacists

Click here to view the letter


A Letter to Congressional Leaders on Medicaid Funding

As a part of our public policy advocacy efforts, NJSHP is one of 24 state affiliates who signed on to a letter drafted by ASHP to Congressional leaders requesting an increase in federal funding for Medicaid and other state-based safety net programs. The goal of this increase is to protect patients' access to care during the COVID-19 emergency. The letter asks that economic stimulus discussions include strategies to maximize the sustainability of Medicaid  so that patients may continue to seek the care they need. This letter is a direct result of feedback from state affiliates, including New Jersey, regarding the impact state budget cuts could have on the healthcare system.


The letter can be found by clicking here.

Yours in service, 

Daniel T. Abazia, PharmD, BCPS, CPPS
President | NJSHP

Policies Approved by the 2020 ASHP House of Delegates

To view the document with the updated policies, please click here to download

Theme picker